Microtransplantation in Older Patients With Acute Myeloid Leukemia

Sponsor
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences (Other)
Overall Status
Completed
CT.gov ID
NCT02831192
Collaborator
(none)
150
1
1
110
1.4

Study Details

Study Description

Brief Summary

The purpose of this study is to see whether HLA-mismatched donor cells infusion with chemotherapy (microtransplantation,MST) could increase complete remission (CR) and improve survival in older patients with acute myeloid leukemia (AML),the investigators conducted a prospective, multicenter clinical trial of HLA-mismatched MST to estimate outcomes and toxicities.

Condition or Disease Intervention/Treatment Phase
  • Biological: microtransplantation
Phase 2

Study Design

Study Type:
Interventional
Actual Enrollment :
150 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
International Multi-center Clinical Study on Microtransplantation for Treatment of Newly Diagnosed Elderly Acute Myeloid Leukemia (EAML)
Study Start Date :
May 1, 2006
Actual Primary Completion Date :
Jul 1, 2015
Actual Study Completion Date :
Jul 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: MST(microtransplantation)

Biological: microtransplantation
HLA mismatched donor mobilized prepheral stem cell infusion

Outcome Measures

Primary Outcome Measures

  1. Graft versus host disease [1 month]

Secondary Outcome Measures

  1. overall survival [2 years]

  2. leukemia free survival [2 years]

  3. complete remission rate [2 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • de novo acute myeloid leukemia

  • age 60-90

  • have HLA mismatched donor

Exclusion Criteria:
  • have no suitable donor or donor refused

  • patient refused to accept donor cells

Contacts and Locations

Locations

Site City State Country Postal Code
1 Affiliated Hospital of Academy of Military Medical Sciences , Beijing Beijing China 100071

Sponsors and Collaborators

  • The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Investigators

  • Study Chair: AI huisheng, MD, Affiliated Hospital of Academy of Military Medical Sciences

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
ClinicalTrials.gov Identifier:
NCT02831192
Other Study ID Numbers:
  • EAML-MST
First Posted:
Jul 13, 2016
Last Update Posted:
Jul 13, 2016
Last Verified:
Jul 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 13, 2016